Sides of My Skin program introduced while Eli Lilly stock moves lower amid oversold signals

Traders Union
All News
Business & Wealth
Companies
Eli Lilly drops 2.05% today

Highlights

LLY is in a sustained downtrend, trading below short-, medium-, and long-term moving averages amid persistent selling pressure.
Oversold indicators, including bearish momentum and low conviction, suggest sellers remain in control with potential for further downside.
LLY is expected to remain rangebound between $860 and $900, with a breakdown below $860 increasing risk of accelerated losses.

The company said these efforts are based on the idea that people often discuss skin health where trust already exists. Eli Lilly invited the public to learn more through its provided online link.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

LLY is trading well below the SMA-20 ($957.03), SMA-50 ($1,007.20), and just under the SMA-200 ($895.65), highlighting sustained pressure from sellers across short-, medium-, and long-term timeframes. The Ichimoku Kijun at $970.78 sits significantly above current price, acting as immediate resistance; near-term support is found at the SMA-200 ($895.65) and the next key support at the SMA-100 ($1,022.03). Immediate resistance is clustered at the SMA-20 ($957.03) and Ichimoku Kijun ($970.78), with the key resistance near the SMA-50 ($1,007.20).

Momentum signals on D1 are bearish with the MACD in sell territory and ADX showing low conviction (14.91, neutral). Multiple oscillators—RSI (29.40, Sell), Stoch RSI (0.00, Oversold), and CCI (-117.37, Oversold)—indicate sharply oversold conditions. BBP highlights clear dominance by sellers with a strongly negative reading and “oversold” classification. The Awesome Oscillator is also neutral to negative and does not provide meaningful support for a bullish move. LLY has fallen $26.78 (2.96%) from last week’s close at $905.37, with the current price sitting at the very bottom of the weekly trading range. Weekly volatility stands at 5.66%, and price action reflects a steady decline from recent highs. In today's session, LLY continues to slide, down 2.05%, reinforcing the prevailing downside pressure.

For the upcoming week, LLY is expected to trade within a normalized range of $860 to $900, keeping it between the 52-week low ($624.40) and well below the 52-week high ($1,133.95). The probability of a price increase is very low (less than 20%), with downside more likely, given only MA-50 on W1 showing a “Buy” while RSI W1, ADX W1, and MACD W1 are mixed or bearish. The baseline scenario is for sideway movement within the $860–$900 band. A bullish scenario would require a decisive breakout above $900 and then above key resistance at $957, but momentum indicators do not currently favor this. The bearish case sees a breach below $860, possibly testing lower weekly supports, especially if the oversold momentum triggers further liquidation.

Previously it was reported that Eli Lilly faced strong bearish momentum with technical pressures dominating its near-term outlook. Building on that backdrop, investors should monitor for signs of renewed support or any decisive moves above resistance, as these may signal a shift in trend direction for the stock.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.